
The authors would like to thank the family members. We also thank C. Bonnardel, L. Boutrand, T. Conway, J. Lynch, S. Slominski, and P. Watson, for their expert assistance. This work was supported by program grants from le Comite Departemental de l'Ain de La Ligue contre le Cancer, the Council for Tobacco Research (grant 127DR@), the U.S. Department of the Army (grant DAMD17-94-J-4340), and the Nebraska State Cancer and Smoking-Related Diseases Grant Program. N.P. is a fellow of the Ligue contre le Cancer de Haute-Savoie.
Ovarian Neoplasms, Nonsense mutation, Incidence, RNA Splicing, Genes, BRCA1, Transcript defect, Breast Neoplasms, Exons, BRCA1, Breast cancer, Ovarian cancer, Mutation, Genetics, Humans, Genetics(clinical), Female, Exon skipping
Ovarian Neoplasms, Nonsense mutation, Incidence, RNA Splicing, Genes, BRCA1, Transcript defect, Breast Neoplasms, Exons, BRCA1, Breast cancer, Ovarian cancer, Mutation, Genetics, Humans, Genetics(clinical), Female, Exon skipping
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 92 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
